Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
出版年份 2022 全文链接
标题
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
作者
关键词
-
出版物
Molecular Autism
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-03-04
DOI
10.1186/s13229-022-00488-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cannabinoid treatment for autism: a proof-of-concept randomized trial
- (2021) Adi Aran et al. Molecular Autism
- A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders
- (2021) CM Díaz-Caneja et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions
- (2021) James T. McCracken et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Novel treatments for autism spectrum disorder based on genomics and systems biology
- (2021) Danielle Baribeau et al. PHARMACOLOGY & THERAPEUTICS
- The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present
- (2021) Antonio M. Persico et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder
- (2021) Andrew W. Zimmerman et al. Molecular Autism
- A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1
- (2021) Mara Parellada et al. Frontiers in Psychiatry
- Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder
- (2021) Spyridon Siafis et al. Brain Sciences
- The Effectiveness of Cobalamin (B12) Treatment for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
- (2021) Daniel A. Rossignol et al. Journal of Personalized Medicine
- Collateral Child and Parent Effects of Function‑Based Behavioral Interventions for Sleep Problems in Children and Adolescents with Autism
- (2021) Laurie L. McLay et al. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
- Oxytocin levels tend to be lower in autistic children: A meta-analysis of 31 studies
- (2021) Simon John et al. AUTISM
- Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder
- (2021) Linmarie Sikich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving Antioxidant Capacity in Children With Autism: A Randomized, Double-Blind Controlled Study With Cysteine-Rich Whey Protein
- (2021) Ana Maria Castejon et al. Frontiers in Psychiatry
- Meta-analysis: Pharmacologic Treatment of Restricted and Repetitive Behaviors in Autism Spectrum Disorders
- (2020) Melissa S. Zhou et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Improving Behavior Challenges and Quality of Life in the Autism Learning Health Network
- (2020) Julia S. Anixt et al. PEDIATRICS
- Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects
- (2020) Marco Solmi et al. World Psychiatry
- CINeMA: An approach for assessing confidence in the results of a network meta-analysis
- (2020) Adriani Nikolakopoulou et al. PLOS MEDICINE
- Vitamin D Supplementation is Beneficial for Children with Autism Spectrum Disorder: A Meta-analysis
- (2020) Liyao Song et al. Clinical Psychopharmacology and Neuroscience
- Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder
- (2020) Sanne Maartje Kloosterboer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- ESCAP practice guidance for autism: a summary of evidence-based recommendations for diagnosis and treatment
- (2020) Joaquin Fuentes et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Practitioner Review: Pharmacological treatment of attention‐deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta‐analysis
- (2020) Rebecca Rodrigues et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis
- (2020) Spyridon Siafis et al. Molecular Autism
- Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 1: A call for change to practice
- (2020) Suhail A. Doi et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Pitfalls of using the risk ratio in meta-analysis
- (2019) Ilyas Bakbergenuly et al. Research Synthesis Methods
- Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-analysis
- (2019) Merrick S. Fallah et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism
- (2019) Karen J. Parker et al. Science Translational Medicine
- A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder
- (2019) Federico Bolognani et al. Science Translational Medicine
- Differential serotonin transporter (5‐HTT) and 5‐HT 2 receptor density in limbic and neocortical areas of adults and children with ASD: implications for SSRI efficacy
- (2019) Cheryl Brandenburg et al. JOURNAL OF NEUROCHEMISTRY
- Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis
- (2019) David Fraguas et al. PEDIATRICS
- Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)
- (2018) Stavros Stivaros et al. Molecular Autism
- 5.16 A Phase 2 Randomized, Placebo-Controlled Trial of Tideglusib, an Orally Administered GSK-3 Beta Inhibitor, in the Treatment of Adolescents With ASD
- (2018) Evdokia Anagnostou et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Effect of age and autism spectrum disorder on oxytocin receptor density in the human basal forebrain and midbrain
- (2018) Sara M. Freeman et al. Translational Psychiatry
- Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy
- (2017) Baibing Chen et al. EPILEPSY & BEHAVIOR
- Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions
- (2017) Enza Lacivita et al. JOURNAL OF MEDICINAL CHEMISTRY
- Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology
- (2017) Oliver D Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
- (2017) Elizabeth M. Berry-Kravis et al. NATURE REVIEWS DRUG DISCOVERY
- A comprehensive systematic review and meta-analysis of pharmacological and dietary supplement interventions in paediatric autism: moderators of treatment response and recommendations for future research
- (2017) A. Masi et al. PSYCHOLOGICAL MEDICINE
- Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
- (2017) E Lemonnier et al. Translational Psychiatry
- Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review
- (2016) K. Jobski et al. ACTA PSYCHIATRICA SCANDINAVICA
- Randomized, Placebo-Controlled Trial of Methyl B12 for Children with Autism
- (2016) Robert L. Hendren et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial
- (2016) Diane C. Chugani et al. JOURNAL OF PEDIATRICS
- La extensión de la declaración PRISMA para revisiones sistemáticas que incorporan metaanálisis en red: PRISMA-NMA
- (2016) Brian Hutton et al. MEDICINA CLINICA
- Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis
- (2016) L. K. Fung et al. PEDIATRICS
- Comparing Efficacy and Side Effects of Memantine vs. Risperidone in the Treatment of Autistic Disorder
- (2016) Nikvarz Nikvarz et al. PHARMACOPSYCHIATRY
- Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis
- (2016) Toshi A Furukawa et al. BMJ Open
- GetReal in network meta-analysis: a review of the methodology
- (2016) Orestis Efthimiou et al. Research Synthesis Methods
- Ranking treatments in frequentist network meta-analysis works without resampling methods
- (2015) Gerta Rücker et al. BMC Medical Research Methodology
- Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data
- (2015) Kirsty M. Rhodes et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis
- (2015) A Masi et al. Translational Psychiatry
- Get real in individual participant data (IPD) meta-analysis: a review of the methodology
- (2015) Thomas P. A. Debray et al. Research Synthesis Methods
- Sulforaphane treatment of autism spectrum disorder (ASD)
- (2014) K. Singh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Graphical Tools for Network Meta-Analysis in STATA
- (2013) Anna Chaimani et al. PLoS One
- Imputation of response rates from means and standard deviations in schizophrenia
- (2013) Myrto T. Samara et al. SCHIZOPHRENIA RESEARCH
- Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment
- (2013) O. A. Panagiotou et al. BMJ-British Medical Journal
- Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
- (2012) Rebecca M Turner et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols
- (2012) Rahul Mhaskar et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Pharmacologic Treatment of Repetitive Behaviors in Autism Spectrum Disorders: Evidence of Publication Bias
- (2012) M. Carrasco et al. PEDIATRICS
- A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders
- (2011) Eric Hollander et al. AMERICAN JOURNAL OF PSYCHIATRY
- Divalproex Sodium vs Placebo for the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorders
- (2009) Eric Hollander et al. NEUROPSYCHOPHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started